104 related articles for article (PubMed ID: 16838067)
21. CASPAR: a hierarchical bayesian approach to predict survival times in cancer from gene expression data.
Kaderali L; Zander T; Faigle U; Wolf J; Schultze JL; Schrader R
Bioinformatics; 2006 Jun; 22(12):1495-502. PubMed ID: 16554338
[TBL] [Abstract][Full Text] [Related]
22. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
Amara D; Wolf DM; van 't Veer L; Esserman L; Campbell M; Yau C
Breast Cancer Res Treat; 2017 Jan; 161(1):41-50. PubMed ID: 27815749
[TBL] [Abstract][Full Text] [Related]
23. High concordance of gene expression profiling-correlated immunohistochemistry algorithms in diffuse large B-cell lymphoma, not otherwise specified.
Hwang HS; Park CS; Yoon DH; Suh C; Huh J
Am J Surg Pathol; 2014 Aug; 38(8):1046-57. PubMed ID: 24705314
[TBL] [Abstract][Full Text] [Related]
24. A co-expression modules based gene selection for cancer recognition.
Lu X; Deng Y; Huang L; Feng B; Liao B
J Theor Biol; 2014 Dec; 362():75-82. PubMed ID: 24440175
[TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.
Hiraga J; Kinoshita T; Ohno T; Mori N; Ohashi H; Fukami S; Noda A; Ichikawa A; Naoe T
Int J Hematol; 2006 Oct; 84(3):248-55. PubMed ID: 17050200
[TBL] [Abstract][Full Text] [Related]
26. Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
Rossi D; Gaidano G
Hematology; 2002 Aug; 7(4):239-52. PubMed ID: 14972786
[TBL] [Abstract][Full Text] [Related]
27. Network regularised Cox regression and multiplex network models to predict disease comorbidities and survival of cancer.
Xu H; Moni MA; Liò P
Comput Biol Chem; 2015 Dec; 59 Pt B():15-31. PubMed ID: 26611766
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
29. Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma.
Gao HY; Wu B; Yan W; Gong ZM; Sun Q; Wang HH; Yang W
Oncol Rep; 2017 Sep; 38(3):1363-1372. PubMed ID: 28713985
[TBL] [Abstract][Full Text] [Related]
30. FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.
Wong KK; Gascoyne DM; Soilleux EJ; Lyne L; Spearman H; Roncador G; Pedersen LM; Møller MB; Green TM; Banham AH
Oncotarget; 2016 Aug; 7(33):52940-52956. PubMed ID: 27224915
[TBL] [Abstract][Full Text] [Related]
31. QuantiGene Plex Represents a Promising Diagnostic Tool for Cell-of-Origin Subtyping of Diffuse Large B-Cell Lymphoma.
Hall JS; Usher S; Byers RJ; Higgins RC; Memon D; Radford JA; Linton KM
J Mol Diagn; 2015 Jul; 17(4):402-11. PubMed ID: 25982535
[TBL] [Abstract][Full Text] [Related]
32. Pathway analysis of informative genes from microarray data reveals that metabolism and signal transduction genes distinguish different subtypes of lymphomas.
Mircean C; Tabus I; Kobayashi T; Yamaguchi M; Shiku H; Shmulevich I; Zhang W
Int J Oncol; 2004 Mar; 24(3):497-504. PubMed ID: 14767533
[TBL] [Abstract][Full Text] [Related]
33. Discovering hidden connections among diseases, genes and drugs based on microarray expression profiles with negative-term filtering.
Wu JS; Kao EF; Lee CN
PLoS One; 2014; 9(6):e98826. PubMed ID: 24915461
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of several gene lists for distinct types of cancer: a simple way to reveal common prognostic markers.
Yang X; Sun X
BMC Bioinformatics; 2007 Apr; 8():118. PubMed ID: 17411443
[TBL] [Abstract][Full Text] [Related]
35. GO-2D: identifying 2-dimensional cellular-localized functional modules in Gene Ontology.
Zhu J; Wang J; Guo Z; Zhang M; Yang D; Li Y; Wang D; Xiao G
BMC Genomics; 2007 Jan; 8():30. PubMed ID: 17250772
[TBL] [Abstract][Full Text] [Related]
36. Peeling off the hidden genetic heterogeneities of cancers based on disease-relevant functional modules.
Xu JZ; Guo Z; Zhang M; Li X; Li YJ; Rao SQ
Mol Med; 2006; 12(1-3):25-33. PubMed ID: 16838067
[TBL] [Abstract][Full Text] [Related]
37. Unravelling the hidden heterogeneities of diffuse large B-cell lymphoma based on coupled two-way clustering.
Zhang W; Li L; Li X; Jiang W; Huo J; Wang Y; Lin M; Rao S
BMC Genomics; 2007 Sep; 8():332. PubMed ID: 17888167
[TBL] [Abstract][Full Text] [Related]
38. Pathway-based analysis of the hidden genetic heterogeneities in cancers.
Zhao X; Zhong S; Zuo X; Lin M; Qin J; Luan Y; Zhang N; Liang Y; Rao S
Genomics Proteomics Bioinformatics; 2014 Feb; 12(1):31-8. PubMed ID: 24462714
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
